Bacteriological and Molecular Study Characterization of Klebsiella pneumoniae Isolated from Different Clinical Specimens

  • Marwan Khalil Qader Department of Biology, College of Science, University of Duhok, Duhok, Kurdistan Region - F.R. Iraq
Keywords: Klebsiella pneumoniae, ESBL, antibiotic susceptibility, UTI


Klebsiella pneumoniae is one of the foremost imperative opportunistic pathogens. Urinary characteristic disease is the common infectious bacterial contamination caused  by K. pneumonia, that  are rising around the world comprising a danger to community and clinic settings. K. pneumonia Isolates were  evaluated for their antimicrobial susceptibility. Samples were taken from 80 patients with  diverse diseases  infection. Genomic DNA of K. pneumonia Confines were extricated  and detection of ESBL Genes was 53.75% of the isolates  were predominance for ESBL  Genes blaTEM, blaSHV and bla CTX-M 82.5, 92.5  and  70 %, respectively. Out of 100 obtained clinical isolates of K. pneumonia from diverse healing centers and therapeutic research facilities in Duhok/ Iraq as it were (80%) isolates had a place to the genus K. pneumonia. Ampicillin and Aztreonam 100 % anti-microbial resistance where was Imipenem Ertapenem Meropenem 100% sensitive. Conveyance of ESBLs creating K. pneumoniae among different clinical tests because it was 71.42% in urine, 40. 90 % in wound swabs, 42. 10 % in sputum and 50 % in blood culture. The recurrence of the ESBL production can easily be thought little of within the clinical isolates of K. pneumoniae with the utilize of the current CLSI suggested strategies, an ideal recognizable proof of the ESBL creating isolates is basic to define approaches for an experimental antimicrobial treatment  


Download data is not yet available.

Author Biography

Marwan Khalil Qader, Department of Biology, College of Science, University of Duhok, Duhok, Kurdistan Region - F.R. Iraq

Mr. Marwan Khalil Qader is currently a lecturer at the Department of Biology, College of Science, University of Duhok, Kurdistan Region, F.R. Iraq. He obtained an M.Sc. in Biology, Molecular Microbiology, from College of Education, University of Duhok in 2010. He graduated from the College of Science, University of Mosul, F.R. Iraq in 2005 with a B.Sc. in Biology. His areas of interest are: Molecular biology and Microbiology.


Al-Zahrani, A. J. & Akhtar, N. (2005). Susceptibility patterns of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae isolated in a teaching hospital. Pakistan Journal of Medical Research, 44(2), 64-67.
Amr, M., Hady El Gilany, A. & El-Hawary, A. (2008). Does gender predict medical students’ stress in Mansoura, Egypt. Medical Education Online, 13, 12.
Bradford, P. A. (2001). Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews, 14(4), 933-951.
Bradford, P. A., Cherubin, C. E., Idemyor, V., Rasmussen, B. A. &Bush, K. (1994). Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: Identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate. Antimicrobial Agents and Chemotherapy, 38(4), 761-766.
Bush, K. (2002).The impact of beta-lactamases on the development of novel antimicrobial agents. Current Opinion in Investigational Drugs, 3(9), 1284-1290.
Chaudhary, U. & Aggarwal, R. (2004). Extended spectrum -lactamases (ESBL) - an emerging threat to clinical therapeutics. Indian Journal of Medical Microbiology, 22(2), 75-80.
Cheesbrough, M. (2006). District Laboratory Practice in Tropical Countries. Part 2, 2nd Edition. Cambridge University.
Falagas, M. E. & Karageorgopoulos, D. E. (2009). Extended-spectrum beta-lactamase-producing organisms. Journal of Hospital Infection, 73(4), 345-354.
Feizabadi, M .M., Etemadi, G., Yadegarinia, D., Rahmati, M., Shabanpoor, S. & Bokaei, S. (2006). Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Medical Science Monitor, 12(11), BR362-BR365.
Golamreza, I. & Moghadas, S. A. J. (2010). Frequency of extended-spectrum beta lactamase positive and multidrug resistance pattern in ram-negative urinary isolates, Semnan, Iran. Jundishapur Journal of Microbiology, 3(3), 107-113.
Huseyin, T. & Hakki, B. I. (2005). Molecular characterization of TEM- and SHV-derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey. Japanese Journal of Infectious Diseases, 58(3), 162-167.
Kahan, N. R., Chinitz, D. P., Waitman, D. A., Dushnitzky, D., Kahan, E. & Shapiro, M. (2006). Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Israel: Another lost treatment option? Annals of Pharmacotherapy, 40(12), 2223-2227.
Kiesser, T. (1995). Preparation and Analysis of Genomic and Plasmid DNA. Norwich: John Innes Center. 17, p. 123-129.
Knothe, H., Shah, P., Krcmery, V., Antal, M. & Mitsuhashi, S. (1983). Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection, 11(6), 315-317.
MacFaddin, J. F. (1999). Biochemical Tests for Identification of Medical Bacteria. 3rd Edition. Philadelphia: Lippincott Williams & Wilkins.
Manikandan, C. & Amsath, A. (2013). Antibiotic susceptibility pattern of Klebsiella pneumoniae isolated from urine samples. International Journal of Current Microbiology and Applied Sciences., 2(8), 330-337.
Mansouri, M. & Ramazanzadeh, R. (2009). Spread of extended-spectrum beta-lactamase producing Escherichia coli clinical isolates in Sanandaj Hospitals. Journal of Biological Sciences, 9(4), 362-366.
Paterson, D. L. & Bonomo, R. A. (2005). Extended-spectrum beta lactamases: A clinical update. Clinical Microbiology Reviews, 18(4), 657–686.
Paterson, D. L. & Bonomo, R. A. (2005). Extended-spectrum beta-lactamases: A clinical update. Clinical Microbiology Reviews, 18(4), 657-686.
Sambrook, J. & Russell, D. W. (2001.). Molecular Cloning. 3rd Edition. New York: Cold Spring Harbor Laboratory Press.
Shahcheraghi, F., Moezi, H. & Feizabadi, M. M. (2007). Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Medical Science Monitor, 13(11), BR247-BR250.
Shannon, K. & Phillips, I. (1986). The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis. Journal of Antimicrobial Chemotherapy, 18, 15-22.
Sobhan, G., Zamberi, S., Nourkhoda, S., Reza, M., Vasantah, K. N., Abbas, M., Ali, H., Mohammad, R., Mohammad, R. & Reza, R. (2011). The prevalence of ESBLs producing Klebsiella pneumoniae isolates in some major hospitals, Iran. The Open Microbiology Journal, 5, 91-95.
Winokur, P. L., Brueggemann, A., DeSalvo, D. L., Hoffmann, L., Apley, M. D., Uhlenhopp, E. K., Pfaller, M. A. & Doern, G. V. (2000). Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrobial Agents and Chemotherapy, 44(10), 2777-2783.
Yu, Y., Zhou, W., Chen, Y., Ding, Y. & Ma, Y. (2002). Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province. Chinese Medical Journal, 115(10), 1479-1482.
Zhang, W., Luo, Y., Li, J., Lin, L., Ma, Y. Hu, C., Jin, S., Ran, L. & Cui, S. (2011). Wide dissemination of multidrug-resistant Shigella isolates in China. Journal of Antimicrobial Chemotherapy, 66(11), 2527-2535.
How to Cite
Qader, M. (2019, December 27). Bacteriological and Molecular Study Characterization of Klebsiella pneumoniae Isolated from Different Clinical Specimens. UKH Journal of Science and Engineering, 3(2), 22-30.
Research Articles